Financing, Equity Capital Markets
Inozyme Pharma, Inc.
07/23
|
$60.0 Million
做厙勛圖 served as bookrunner for Inozyme Pharma, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma